Dying T lymphocytes call for the death of tumor cells |
| |
Authors: | Shi Yufang Roberts Arthur I Sun Erwei |
| |
Institution: | Department of Molecular Genetics, Microbiology and Immunology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA. |
| |
Abstract: | Immunotherapy that specifically targets tumor cells is the preferred approach to induce tumor regression. Over the past decade, significant progress has been made in devising various methods to direct the immune system to respond to tumor cells. The major hurdle for successful immunotherapy is to overcome immune tolerance in the tumor microenvironment. Recent clinical trials with dendritic cell-based vaccination 1, 2] and CTLA4 blocking antibodies 3] have shown great promise, though complete cancer regression is not always achieved 4]. Currently, alternative strategies potentially leading to cancer eradication or regression in animal or clinical models are being enthusiastically pursued. In this issue of Cell Research, Wang et al. report a novel way to induce tumor immunity by the use of irradiated autologous T cells 5]. |
| |
Keywords: | |
本文献已被 CNKI 维普 PubMed 等数据库收录! |
|